Click to Share

Filter News
Show All Results
News By Country
News By Tag
Drug Development Remove

December 2021
November 2021

Public Company News

Business Press Releases

Drug Development Press Releases

Exclusive News
Topics Locations Industries Dates

By SocraTec R&D GmbH
On October 26th, 2021 the German Contract Research Organisation SocraTec R&D GmbH celebrated the opening of their new intensive monitoring clinical unit.
By Neurolixis
The United States Patent and Trademark Office (USPTO) has issued a patent on NLX-112, a drug candidate developed by Neurolixis for treatment of human movement disorders, notably levodopa-induced dyskinesia in Parkinson's disease.

Page updated every 10 minutes

Like PRLog?
Click to Share